Elite in Cirrhosis

Dr. Don Rockey

Gastroenterology
MUSC University Hospital
171 Ashley Ave, 
Charleston, SC 
Offers Telehealth
Elite in Cirrhosis
MUSC University Hospital
171 Ashley Ave, 
Charleston, SC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Don Rockey is a Gastroenterologist in Charleston, South Carolina. Dr. Rockey is rated as an Elite provider by MediFind in the treatment of Cirrhosis. His top areas of expertise are Gastrointestinal Bleeding, Portal Hypertension, Cirrhosis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 364 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 114 articles and participated in 2 clinical trials in the study of Cirrhosis.

Specialties
Gastroenterology
Licenses
Internal Medicine in SC
Hospital Affiliations
Musc Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
View 1 Less Insurance Carrier -

Locations

MUSC University Hospital
171 Ashley Ave, Charleston, SC 29425
Other Locations
Office
96 Jonathan Lucas St Rm HE904M, Charleston, SC 29425

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Enrollment Status: Terminated
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients
A Randomized, Double-blind, Placebo-controlled Pilot Study to Assess the Safety and Efficacy of Ifetroban for the Treatment of Portal Hypertension in Cirrhotic Patients
Enrollment Status: Completed
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
A Phase 2 Double-blind, Randomized, Placebo-controlled, Dose-finding Study to Evaluate the Safety, Tolerability and Efficacy of Volixibat Potassium, an Apical Sodium-Dependent Bile Acid Transporter Inhibitor (ASBTi) in Adults With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Terminated
Publish Date: November 25, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
A Randomized, Placebo-controlled, Double-blinded Study of the Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
Enrollment Status: Terminated
Publish Date: November 18, 2019
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
Enrollment Status: Withdrawn
Publish Date: June 14, 2018
Intervention Type: Dietary supplement, Device
Study Phase: Not Applicable
View 6 Less Clinical Trials

364 Total Publications

Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver Disease.
Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With α-1 Antitrypsin Deficiency-Associated Liver Disease.
Journal: Gastroenterology
Published: October 08, 2025
Similar Doctors
Distinguished in Cirrhosis
Dr. Ira Willner
Gastroenterology
Distinguished in Cirrhosis
Dr. Ira Willner
Gastroenterology

Pain Management At Rutledge Tower

135 Rutledge Ave Fl 9, 
Charleston, SC 
 (1.2 miles away)
843-792-5097
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ira Willner is a Gastroenterologist in Charleston, South Carolina. Dr. Willner is rated as a Distinguished provider by MediFind in the treatment of Cirrhosis. His top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Hepatitis, Enlarged Liver, Endoscopy, and Liver Transplant.

Nathan Shores
Advanced in Cirrhosis
Dr. Nathan Shores
Gastroenterology
Advanced in Cirrhosis
Dr. Nathan Shores
Gastroenterology

Charleston Endoscopy Center

1962 Charlie Hall Blvd, 
Charleston, SC 
 (6.0 miles away)
843-722-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nathan Shores is a Gastroenterologist in Charleston, South Carolina. Dr. Shores is rated as a Distinguished provider by MediFind in the treatment of Cirrhosis. His top areas of expertise are Jaundice, Visceromegaly, Hepatitis, Endoscopy, and Liver Transplant.

Advanced in Cirrhosis
Dr. William Marsteller
Gastroenterology
Advanced in Cirrhosis
Dr. William Marsteller
Gastroenterology

Charleston Endoscopy Center

1962 Charlie Hall Blvd, 
Charleston, SC 
 (6.0 miles away)
843-722-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

William Marsteller is a Gastroenterologist in Charleston, South Carolina. Dr. Marsteller is rated as a Distinguished provider by MediFind in the treatment of Cirrhosis. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Familial Adenomatous Polyposis, Turcot Syndrome, Gastrectomy, and Endoscopy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rockey's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile